Cardiomyopathy chest x ray

Cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines

2023 ESC Guideline Recommendations

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

Case Studies

Case #1

Cardiomyopathy chest x ray On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiomyopathy chest x ray

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiomyopathy chest x ray

CDC on Cardiomyopathy chest x ray

Cardiomyopathy chest x ray in the news

Blogs on Cardiomyopathy chest x ray

Directions to Hospitals Treating Cardiomyopathy

Risk calculators and risk factors for Cardiomyopathy chest x ray

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Lina Ya'qoub, MD; Edzel Lorraine Co, DMD, MD[2]

## Overview

[edit | edit source]

A chest x ray also shows fluid build-up in the lungs, which can be a sign of the complication of heart failure, or an enlarged heart (cardiomegaly) which is usually seen in dilated cardiomyopathy.

## Cardiomyopathy Chest X Ray

[edit | edit source]

A chest x ray also shows fluid build-up in the lungs, which can be a sign of the complication of heart failure, or an enlarged heart (cardiomegaly) which is usually seen in dilated cardiomyopathy.[1]

## References

[edit | edit source]

1. ↑ Sisakian H (June 2014). "Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies". World J Cardiol. 6 (6): 478–94. doi:10.4330/wjc.v6.i6.478. PMID 24976920.

Template:WH Template:WS